Reported Oct 2, 2019 · Terminated
Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only,…
Cardinal Health dba Specialty Pharmaceutical Services
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Cardinal Health dba Specialty Pharmaceutical Services · 15 Ingram Blvd · La Vergne, TN · 37086-3630
Is this the product you have?
- Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.
- Lot codes and dates
Lot #: S25XExp. 03/31/21
- Amount recalled
- 38 syringes
Where it was sold
- Nationwide
Why it was recalled
Temperature Abuse; Product stored and shipped outside of labeled storage requirements.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Cardinal Health dba Specialty Pharmaceutical… recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.